Alexander Schwenger

Alexander has more than 10 years of experience in the field of mRNA/LNP gained in academia and the pharmaceutical industry. After completing his Diploma degree, he specialized in nucleic acid chemistry and nano structuring and received his PhD from the University of Stuttgart. He has a long list of publications and has worked in various roles of increasing responsibility at Curevac SE Germany. Since June 2023, Alex is leading the process development for nucleic acid delivery systems at Lonza (Netherlands) and strives to bring this modality to a new level.